ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,837Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1442

$1.45M Total Retail Price of All Prescriptions

Rank: 6 out of 1442

1,493 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 13,155 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$105 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
ISOSORBIDE MONONITRATE ER 752 725 1 17
PLAVIX 733 669 2 14
METOPROLOL SUCCINATE 649 628 3 1
SIMVASTATIN 615 578 4 2
AMLODIPINE BESYLATE 596 585 5 3
WARFARIN SODIUM 579 532 6 9
RANEXA 512 479 7 29
CLOPIDOGREL 437 401 8 12
DIOVAN 416 400 9 19
METOPROLOL TARTRATE 402 373 10 6
NEXIUM 390 369 11 34
ATORVASTATIN CALCIUM 346 319 12 4
CARVEDILOL 323 301 13 8
ATENOLOL 264 254 14 11
CRESTOR 260 247 15 10
LOSARTAN POTASSIUM 217 201 16 13
LOVAZA 202 173 17 37
OMEPRAZOLE 200 187 18 21
DIGOXIN 184 165 19 15
LISINOPRIL 183 173 20 7
EVISTA 158 153 21 73
DIOVAN HCT 158 158 21 35
LIPITOR 152 145 23 24
ALENDRONATE SODIUM 148 146 24 46
DILTIAZEM 24HR CD 144 136 25 59
ENALAPRIL MALEATE 138 123 26 23
FLUOCINONIDE 137 133 27 253
TAMSULOSIN HCL 131 130 28 38
NITROSTAT 126 116 29 44
LIDODERM 119 113 30 76
BENICAR 105 105 31 61
ZOLPIDEM TARTRATE 99 97 32 25
PRAVASTATIN SODIUM 99 97 32 20
MECLIZINE HCL 92 92 34 83
METFORMIN HCL 88 88 35 26
FUROSEMIDE 87 84 36 5
PRADAXA 70 69 37 27
NIFEDIPINE ER 68 57 38 39
ISOSORBIDE DINITRATE 67 67 39 144
LOSARTAN-HYDROCHLOROTHIAZIDE 65 62 40 30
VYTORIN 62 59 41 101
XARELTO 58 55 42 74
JANUVIA 58 58 42 45
BYSTOLIC 58 53 42 32
VOLTAREN 58 56 42 137
COUMADIN 56 50 46 41
FINASTERIDE 56 55 46 87
SINGULAIR 55 55 48 93
TRICOR 55 44 48 100
EFFIENT 54 51 50 98
ADVAIR DISKUS 53 53 51 79
POTASSIUM CHLORIDE 52 51 52 33
MICARDIS 52 52 52 126
ALLOPURINOL 52 50 52 47
RAMIPRIL 50 50 55 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.